Ever

Short answer Start by asking your clinician for FDA‑approved hormone therapy — ideally bioidentical estradiol and (if you have a uterus) micronized progesterone — rather than unregulated compounded BHRT. If standard options don’t control symptoms or you have special needs, consider compounded “BHRT” only after careful discussion and using a reputable compounding pharmacy. What “BHRT” vs “traditional HRT” means (quick) “Traditional” HRT usually refers to FDA‑approved estrogen and progestin products. Some are bioidentical molecules (estradiol, micronized progesterone); others are synthetic progestins (medroxyprogesterone). “BHRT” is a marketing term that can mean either FDA‑approved bioidentical hormones (same chemical structure as human hormones) or custom‑made, non‑FDA‑tested preparations from compounding pharmacies. The latter are what people usually mean by “compounded BHRT.” Why I recommend FDA‑approved bioidentical options first Consistent potency, manufacturing standards, labeled dosing, and safety data (FDA oversight). Easier to monitor and adjust safely. Some FDA‑approved products are bioidentical (same chemical structure) — you can get the “bioidentical” hormones without the downsides of compounding. Specific FDA‑approved brands/services to ask about (examples) Estradiol (estrogen) Transdermal patches: Vivelle‑Dot, Climara — transdermal route lowers blood clot risk vs oral in many people. Oral estradiol: Estrace (estradiol tablets). Transdermal gel/spray: EstroGel, Evamist (if you prefer non‑patch topical). Progesterone (if you have a uterus) Prometrium (micronized progesterone) — a bioidentical progesterone with FDA data (different risk profile than synthetic progestins). Combination bioidentical product Bijuva (oral combined estradiol + progesterone) — FDA‑approved combined bioidentical product for menopausal symptoms. Alternatives for women who can’t take estrogen Duavee (conjugated estrogen + bazedoxifene) for some postmenopausal women (bone/vasomotor symptoms) — not appropriate if you still have a uterus and need progestin in the usual way; discuss with clinician. Compounded BHRT (caution) Compounded creams, troches, or custom mixes may be useful in specific situations (allergies to components, unusual dosing), but: They are not FDA‑approved, have variable potency and consistency, and lack long‑term safety data. If you pursue compounding, use a high‑quality, accredited compounding pharmacy (check USP <795>/<797> compliance and pharmacist/physician references) and insist on certificate of analysis and clear monitoring plan. Where to get care Primary routes: Your OB‑GYN or primary care doctor (start here if you have an ongoing provider). A menopause specialist (board‑certified gynecologist or internist with menopause expertise). Use the North American Menopause Society (NAMS) provider directory or major centers (Mayo Clinic, Cleveland Clinic) if you need a specialist. Reputable telemedicine services specializing in menopause/HRT (e.g., BodyLogicMD, Ever/Modern Menopause clinics, or large telemedicine platforms that connect to OB‑GYNs). Confirm they prescribe FDA‑approved products and provide follow‑up and monitoring. Compounding pharmacies (if used) — examples known in the field include Wedgewood Pharmacy and other nationally used compounding labs, but vet any pharmacy carefully. Avoid services that promise “natural” cures without discussion of risks/monitoring or that recommend testing panels (saliva hormone panels) that aren’t clinically useful for treatment decisions. What to ask your clinician (script) “Which hormone options do you recommend for my symptoms and medical history?” “Can we use FDA‑approved estradiol and micronized progesterone (or Bijuva) instead of compounded hormones?” “Given my age, smoking, clotting history, breast cancer risk, and cardiovascular risk, what route and dose are safest?” “How will we monitor symptoms and side effects? What baseline tests do you recommend (mammogram, blood pressure, lipids, etc.) and how often?” “If standard options don’t work, what are the pros and cons of compounded BHRT for me?” Safety and monitoring — key points HRT reduces vasomotor symptoms and can improve quality of life. Risks (breast cancer, VTE, stroke, heart disease) depend on age, time since menopause, dose, and formulation. Generally safer if started before age ~60 or within 10 years of menopause onset. Transdermal estradiol may carry lower VTE risk than oral estradiol. Use the lowest effective dose and reassess regularly (6–12 weeks initially, then every 6–12 months). Baseline and routine monitoring: blood pressure, breast cancer screening per guidelines, lipid/glucose testing as indicated, and reassessment of symptoms and side effects. Bottom line recommendation Ask for FDA‑approved, bioidentical estradiol (prefer transdermal if clot risk) plus micronized progesterone (Prometrium) if you need progestogen; ask about Bijuva if you want a combined oral bioidentical option. Reserve compounded BHRT only for specific, justified cases and only from a well‑vetted compounding pharmacy with an explicit monitoring plan. If you want, tell me your age, symptoms, medical history (esp. clotting, breast cancer, smoking, cardiovascular disease), and whether you still have a uterus — I can give a more tailored suggestion and wording to bring to your clinician.

Mentioned in position 10 of 12